Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events

por Jialal, Ishwarlal, Olatunbosun, Samuel
Publicado 2023

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome

por Devaraj, Sridevi, Jialal, Ishwarlal
Publicado 2012

Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323

por Jialal, Ishwarlal, Devaraj, Sridevi
Publicado 2014

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy

por Rajamani, Uthra, Jialal, Ishwarlal
Publicado 2014

Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”

por Rajamani, Uthra, Jialal, Ishwarlal
Publicado 2016

Fetuin-A is also an adipokine

por Jialal, Ishwarlal, Pahwa, Roma
Publicado 2019

Management of diabetic dyslipidemia: An update

por Jialal, Ishwarlal, Singh, Gurdeep
Publicado 2019

AHA/ACC/Multisociety Cholesterol Guidelines: highlights

por Jialal, Ishwarlal, Devaraj, Sridevi
Publicado 2019

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

por Jialal, Ishwarlal, Vikram, Naval
Publicado 2021

Correlates of Insulin Resistance in Nascent Metabolic Syndrome

por Adams-Huet, Beverley, Jialal, Ishwarlal
Publicado 2023

Adipose Tissue Dysfunction in Nascent Metabolic Syndrome

por Bremer, Andrew A., Jialal, Ishwarlal
Publicado 2013

Management of Hypertriglyceridemia in the Diabetic Patient

por Jialal, Ishwarlal, Amess, William, Kaur, Manpreet
Publicado 2010

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?

por Devaraj, Sridevi, Siegel, David, Jialal, Ishwarlal
Publicado 2010

SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome

por Ramakrishnan, Neeraj, Jialal, Ganesh, Jialal, Ishwarlal
Publicado 2020

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome

por Jialal, Ishwarlal, Adams-Huet, Beverley, Devaraj, Sridevi
Publicado 2023

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

por Devaraj, Sridevi, Valleggi, Simona, Siegel, David, Jialal, Ishwarlal
Publicado 2010

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

por Dasu, Mohan R., Devaraj, Sridevi, Park, Samuel, Jialal, Ishwarlal
Publicado 2010

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

por Cole, Justine, Zubirán, Rafael, Wolska, Anna, Jialal, Ishwarlal, Remaley, Alan T.
Publicado 2023

Exploratory metabolomics of metabolic syndrome: A status report

por Lent-Schochet, Daniella, McLaughlin, Matthew, Ramakrishnan, Neeraj, Jialal, Ishwarlal
Publicado 2019

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome

por Jialal, Ishwarlal, Huet, Beverley A., Kaur, Harmeet, Chien, Alexander, Devaraj, Sridevi
Publicado 2012